ArticleAdvances in therapy2024

Cost-effectiveness of Finerenone in Addition to Standard of Care for Patients with Chronic Kidney Disease and Type 2 Diabetes in China.

Jian Ming et al.PubMed ↗Publisher ↗

No numbers read from the abstract.